and detection of complex
genetic changes
Applications
Cellular Engineering
Monitoring Cellular Engineering Outcomes
On/Off Target Effects
Orthogonal Data for Sequencing
Variant Discovery
Genomic Stability Assessment
Radiation Biodosimetry
directional Genome Hybridization (dGH)
Structural Rearrangements
Inversions
Translocations
KromaTiD News
Videos, Presentations & Webinars
- KromaTiD: Who We Are
- KromaTiD’s Cell Culture Services Protocol
- Dr. Chris Tompkins and Erin Cross present webinar for the launch of dGH SCREEN™ for unbiased whole genome analysis of chromosomal structural rearrangements
- Dr. Lauren Kinner-Bibeau presents webinar on single-cell measurements of genomic inserts and transgenes
- KromaTiD presents at the 2020 virtual NextGen Omics Series
- KromaTiD CTO Dr. Chris Tompkins presents at the 2020 Cell & Gene Therapy Virtual Congress
Market News
- Bay Area Biotech is Taking Gene Therapy to the Next Level with Chemogenomics
- CRISPR-Editing Biotech Arbor Bio adds $215M for Liver, CNS Diseases Therapies
- A Gene-Editing Experiment Let These Patients With Vision Loss See Color Again
- Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis
- A CRISPR gene-editing breakthrough stops life-threatening disease in Intellia-sponsored study